Microbot Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -360.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | +129.5% | – | |
| – | – | – | +0.0% | -50.0% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -22.2% | +14.3% | +75.0% | -25.0% | +9.5% | +8.7% | +32.0% | -24.2% | +4.0% | -23.1% | +75.0% | -20.0% | -50.0% | +64.3% | +13.0% | -42.3% | -20.0% | -16.7% | +0.0% | +930.0% | +758.3% | – | |
| – | -360.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -32,250.0% | – | |
| – | +2,253.5% | -97.7% | +104.9% | -10.1% | -41.0% | +148.0% | +50.6% | -16.6% | +22.3% | -23.0% | +26.2% | +13.8% | -0.2% | -17.8% | -3.2% | +55.0% | -3.7% | +12.0% | +24.1% | +0.0% | +62.4% | -24.4% | +28.5% | -10.9% | -3.5% | -14.2% | -15.6% | +18.1% | -32.1% | +4.2% | +24.2% | +45.4% | -5.0% | -25.5% | +43.9% | -44.2% | +31.7% | -16.1% | +43.9% | – | |
| – | -59.2% | +34.5% | -15.6% | +1.2% | +31.8% | -13.7% | +12.4% | -1.3% | -3.2% | +21.5% | -39.5% | +17.9% | +3.6% | +49.9% | -17.5% | +13.4% | +18.1% | -21.8% | -14.6% | +7.0% | +44.5% | -12.6% | -6.8% | +11.0% | -22.2% | +10.0% | -26.3% | -2.8% | +0.6% | +29.5% | -10.0% | +13.3% | +16.6% | +8.0% | +3.2% | +66.9% | -11.4% | +27.1% | – | – | |
| – | -478.1% | – | +2.4% | -2.1% | +24.5% | -1.4% | +24.9% | -7.3% | +18.9% | -8.1% | -19.4% | +15.9% | +11.0% | +8.8% | -12.9% | +28.2% | +8.8% | -8.9% | +3.5% | +3.1% | +54.3% | -19.3% | +12.2% | -2.5% | -11.7% | -4.9% | -20.4% | +9.5% | -20.1% | +15.9% | +6.6% | +31.4% | +3.2% | -11.3% | +22.8% | +4.0% | +7.2% | +4.4% | +28.3% | – | |
| – | – | -111.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,247.8% | -42.1% | +1,221.2% | -97.9% | +9,470.8% | -98.9% | -96.0% | +150.0% | +960.0% | -15.1% | -93.3% | +2,666.7% | -73.5% | +90.9% | -31.0% | +96.6% | -82.5% | -60.0% | +775.0% | -91.4% | +2,500.0% | -83.3% | +27,280.7% | -99.8% | +16.7% | +842.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -180.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -67,935.6% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -83.3% | -27,480.7% | – | – | – | – | – | +10.8% | -123.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -180.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -175.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.